Senti Biosciences Holdings, Inc.
Biotechnology · South San Francisco, CA
BiotechnologySEC Form D
Senti Biosciences Holdings, Inc. filed a Form D with the U.S. Securities and Exchange Commission on June 4, 2026, reporting $10,000,000 raised toward a $40,000,000 offering.
Incorporated in Delaware and based in South San Francisco, CA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Senti Biosciences Holdings, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Timothy LuExecutive Officer · Director
- Edward MathersDirector
- Frances D. SchulzDirector
- Donald TangDirector
- Brenda CooperstoneDirector
- James J. CollinsDirector
- Feng HsiungDirector
- Bryan BaumDirector
- Jay CrossExecutive Officer
- Kanya RajangamExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$1.6MRaised